The firm has advised several multinational and Bangladeshi companies in the area of healthcare, food and pharmaceutical. The firm has experience, in-depth knowledge and understanding of the legal and regulatory framework relating to legislations dealing with healthcare, food and pharmaceutical industry including prevention of food adulteration legislation.
We offer comprehensive service to clients on introduction, import and marketing of Generic and New Drugs including bulk drugs in the Bangladesh market. We have also undertaken various issues arising out of international treaties such as Declaration of Helsinki, Good Clinical Practice guidelines and the Agreement on Trade Related Aspects of Intellectual Property Rights especially Article 39.3 concerning interpretation of data exclusivity/ protection.
The firm has extensive experience in advising and providing legal assistance on agreements relating to manufacturing, marketing, import, sponsorship of drugs (generic and non-generic drugs including herbal medicines), regulatory approvals from relevant statutory authorities, approvals and compliances in relation to clinical trials; intellectual property protection and registration such as Patents, Trademarks etc. and agreements relating to licensing of know-how etc., labeling and packaging guidelines, issues relating to food adulteration, advisory to Hospitals and World Class Health Institutions in structuring their businesses in cross border jurisdictions; advisory and assistance in corporate commercial issues including company incorporation, joint venture partnerships, acquisitions etc. and structuring of Foreign Investment and related regulatory approvals.
Some major matters undertaken are as follows:
